Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function (NCT05693441) | Clinical Trial Compass
CompletedNot Applicable
Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function
Sweden62 participantsStarted 2023-01-17
Plain-language summary
The aim of the current study is to investigate whether acute and 12-weeks daily intake of Nordic berries can improve cognitive abilities of adults without cognitive disease, and whether the effect can be linked to changes in metabolic parameters.
Who can participate
Age range60 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 60-85 years.
✓. Capable and willing to give written informed consent.
✓. Capable and willing to perform cognitive testing in Swedish (mastering the Swedish language, functional vision and hearing or the use of visual or hearing aids during testing).
✓. Capable and willing to ingest the study beverage for 12 weeks and to follow the instructions given.
✓. Agree to maintain consistent dietary habits and physical activity levels for the duration of the study
Exclusion criteria
✕. Known to be affected by major neurocognitive disorder/dementia or low score on cognitive screening test (Mini Mental State Examination (MMSE) score less than 24.
✕. Affected by other medical condition(s) or medication(s) known to significantly affect cognitive function.
✕. Past history of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery or stroke.
✕. Underweight (BMI \<18.5).
✕. Significant psychiatric disorders with current symptoms.
✕. Type 1 diabetes, recently diagnosis of Type 2 diabetes (\<12 months) or ongoing insulin treatment.
✕. Ongoing treatment for malignancy\*.
What they're measuring
1
Cognitive measures-memory
Timeframe: Change from baseline following 12 weeks daily consumption, compared to control
2
Cognitive measures-memory
Timeframe: Change from baseline following 12 weeks daily consumption, compared to control
3
Cognitive measures - memory
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
4
Cognitive measures - memory
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
5
Cognitive measures - executive function
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
6
Cognitive measures - executive function
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
7
Cognitive measures - executive function
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control